FDA inspection
North China Pharmaceutical Huasheng Co., LTD: FDA inspection ending Sep 6, 2024
FDA inspection 1251737 · No Action Indicated (NAI) · Shijiazhuang
Key facts
| Inspection ID | 1251737 |
|---|---|
| Firm | North China Pharmaceutical Huasheng Co., LTD |
| FEI number | 3003001488 |
| Address | No 8 Yangzi Road, Shijiazhuang Economic and Technological Development Zone |
| City | Shijiazhuang |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Sep 6, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data